The chemical class known as Ribosomal Protein L26 Activators encompasses a diverse range of compounds that specifically target and upregulate the expression of Ribosomal Protein L26 (RPL26), a critical component of the ribosomal machinery in cells. These activators operate through various biochemical pathways to enhance the production or functional efficiency of RPL26, thus playing a pivotal role in the intricate process of protein synthesis. The mechanisms of action for these activators are multifaceted and sophisticated, often involving the modulation of upstream regulatory pathways or direct interaction with the gene regulatory elements responsible for RPL26 expression. This unique class of chemicals is characterized by their specificity in influencing RPL26, distinguishing them from broader spectrum ribosomal or protein synthesis modulators.
The precise functioning of RPL26 activators involves intricate interactions at the molecular level. Some activators may function by binding to regulatory sequences in the DNA that controls the expression of the RPL26 gene, thereby enhancing its transcription. Others might interact with the ribosome assembly process, ensuring that RPL26 is efficiently incorporated into the ribosome complex. Additionally, certain activators in this class may exert their effects indirectly by modulating signaling pathways that ultimately lead to increased synthesis or stabilization of RPL26. These pathways could include, but are not limited to, the mTOR pathway, known for its central role in regulating protein synthesis, or epigenetic mechanisms like histone modification and DNA methylation, which can alter gene expression patterns. This versatility in the mode of action allows for a range of compounds with varying molecular structures and origins to be included in the category of RPL26 activators, making it a rich field of study in molecular and cellular biology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Could upregulate RPL26 by inhibiting the mTOR pathway, a critical regulator of protein synthesis, potentially leading to compensatory mechanisms that increase RPL26 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an HDAC inhibitor, it might enhance RPL26 expression by altering chromatin structure and increasing the accessibility of the RPL26 gene for transcription. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
By activating AMPK, it could enhance metabolic pathways that lead to an upregulation of protein synthesis machinery, including RPL26. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Could upregulate RPL26 by altering DNA methylation patterns, leading to increased transcription of the RPL26 gene. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Might upregulate RPL26 as part of its role in cell differentiation and growth, which often involves increased protein synthesis. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Could promote RPL26 expression by regulating gene expression and cellular differentiation processes that require increased protein synthesis. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Might promote RPL26 expression as part of its impact on gene expression and neuronal plasticity, which involves protein synthesis. | ||||||